Premier provider of Medical Device Systems and Supplies Strengthens Executive Team
CHESTER, NY / ACCESSWIRE / January 20, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) ("RMS" or the
"Company") announced today that Mr. Eric Bauer has joined the executive team as Chief Operating Officer, effective January 17,
2017. Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing organizations within FDA
regulated environments.
Prior to joining RMS Medical Products, Mr. Bauer was Chief Executive Officer of 2020Value, LLC, a consulting business leveraging
his extensive operating experience to help clients maximize long-term sustainable value. From 2011 to 2015, Mr. Bauer served as
Founder and Chief Executive Officer of KAKO Beauty Products, a cause-oriented provider of skin care goods benefiting the Medical
Research Center for Childhood Cancer. From 2008 to 2011, Mr. Bauer was the Chief Executive Officer of Chemaid Laboratories, a
Private Equity-owned contract manufacturing company providing high quality skin care, haircare, fragrance, and bath products to the
prestige cosmetics industry. At Chemaid, Mr. Bauer emphasized a culture focused on operational excellence, product quality, and
customer service, resulting in a doubling of revenue, 400% increase in EBITDA, and significantly increasing shareholder value
during his tenure. From 2002 to 2008, Mr. Bauer served as President of Valois of America, Inc., an international consumer packaged
goods manufacturing company providing high quality pumps to the Luxury Fragrance/Cosmetic and Pharmaceutical Industries in North
America. As President, Mr. Bauer oversaw operations with FDA regulated Class 10,000 clean rooms and had responsibility for all
manufacturing, sales, and service. During his six year tenure with Valois, Mr. Bauer spearheaded $80 million in sales growth from
$40M to $120M and increased productivity by 200%. Mr. Bauer began his career with Eastman Kodak where he served in various
managerial positions over his 22 years tenure with the company. Mr. Bauer earned his MBA in Finance and Economics at the University
of Rochester and his BS in Industrial Engineering at the State University of Buffalo. Mr. Bauer also attended Executive Development
Programs at Duke University, MIT, and Columbia University.
Andrew Sealfon, CEO of RMS, stated, "Bringing Eric on board reaffirms our commitment to a robust growth strategy coupled with
delivering long-term value to our shareholders. With Eric's experience in successfully building and managing businesses from the
tens to hundreds of millions of revenue, he will be instrumental in helping us achieve accelerating organic revenue growth, while
maintaining our strong brand reputation in the market and streamlining operations to ensure efficient execution as we grow. We are
delighted Eric has joined the RMS team and look forward to his dynamic contributions with a promise of bright future."
Mr. Bauer commented, "I'm thrilled to be a part of the RMS team. It is an honor to be part of such a highly respected
organization dedicated to improving the quality of life of so many patients around the world. With an exciting new product pipeline
and expansion of global sales, the future of RMS is very bright."
About RMS Medical Products
The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes
the FREEDOM60® and our latest FreedomEdge® Syringe Infusion Pumps, RMS Precision Flow Rate Tubing™, and RMS HIgH-Flo™ Subcutaneous
Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings, as well as at home. The
Company's RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers, in addition to a variety
of other healthcare providers.
The Company's website may be visited at www.rmsmedicalproducts.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe
such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects,"
"intends," "anticipates," "will," or "plans," to be uncertain and forward-looking. The forward-looking statements contained herein
are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports and
registration statements filed with the Securities and Exchange Commission.
For more information, please call:
Mike King 702 650 3000 Princeton Research
SOURCE: Repro Med Systems, Inc.
